Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Mandala of Health : A Scientific Journal
Wisudarti, Calcarina Retno Fitriani
Unknown Affiliation
Dentistry Health Professions Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
ENCEPHALITIS ANTI N-METHYL-D-ASPARTATE RECEPTORS Suryani, Shila; Wisudarti, Calcarina Retno Fitriani
Mandala Of Health Vol 16 No 2 (2023): Mandala of Health
Publisher : Fakultas Kedokteran Universitas Jenderal Soedirman

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20884/1.mandala.2023.16.2.8584

Abstract

Background : Anti-N-Methyl-D-Aspartate receptor encephalitis is an autoimmune disease where the incidence is still rare which is characterized by complex neuropsychiatric syndrome. In severe stages, it can cause morbidity and mortality so it requires adequate intensive therapeutic management. Cases: 1) Male, 23 years old diagnosed with NMDAR encephalitis at an advanced stage in 10 days of treatment. Patient was given plasma exchange therapy three times and steroids did not respond then given rituximab, did not respond as expected. 2) A 19-year-old male diagnosed with NMDAR encephalitis at an advanced stage on the 7th day of hospitalization. Patient was given plasma exchange therapy 7 times and steroids. The patient showed an improved response to the third plasma exchange therapy, the patient could weaned from the ventilator and then transferred from the ICU. Conclusion: NMDAR encephalitis at an advanced stage requires long intensive care. Immunotherapy is the first-line therapy for NMDAR encephalitis. Immunotherapy options in severe cases can be given plasma exchange in combination with steroids. Rapid diagnosis and early initiation of therapy can provide better outcomes, reduce complications of nosocomial infections and reduce length of stay in the ICU.
Co-Authors Shila Suryani, Shila